SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: NASDAQ:), a clinical-stage biotechnology firm pioneering immuno-neurology, in the present day introduced that administration will take part in a hearth chat on the Goldman Sachs 45th Annual World Healthcare Convention on Monday, June 10, 2024, at 1:20 p.m. ET.
A dwell webcast of the fireplace chat might be obtainable on the Occasions & Shows web page throughout the Buyers part of the Alector web site at http://traders.alector.com. A replay might be obtainable on the Alector web site for 90 days following the occasion.
About Alector
Alector is a clinical-stage biotechnology firm pioneering immuno-neurology, a novel therapeutic method for the therapy of neurodegenerative ailments. Immuno-neurology targets immune dysfunction as a root explanation for a number of pathologies which are drivers of degenerative mind issues. Alector has found and is growing a broad portfolio of innate immune system applications, designed to functionally restore genetic mutations that trigger dysfunction of the mind’s immune system and allow rejuvenated immune cells to counteract rising mind pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and search to deal with indications, together with Alzheimer’s illness and genetically outlined frontotemporal dementia affected person populations. Alector is headquartered in South San Francisco, California.
Alector Contacts:
Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com
1AB (media)
Dan Budwick
973-271-6085
dan@1abmedia.com
Argot Companions (traders)
Laura Perry
212.600.1902
alector@argotpartners.com